Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Varenka Rodriguez"'
Autor:
Jessica Potts, Emily Corse, Joseph Tumang, Pratha Budhani, Abhishek Kashyap, Xiaoyun Liao, Candace Wai Sze Lei, John Holt, Brianna Flynn, Richard Barrett, Mohanapriya Kamalakannan, Ruby Wasti, Lucinda Thiede, Joshua Tagore, Jacqueline Larouche, Marie Marcher, Sarah O’Brien, Jeanine Pignatelli, Kang Liu, Ben Stanger, Ellen Pure, Varenka Rodriguez DiBlasi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/0c3c04dd78ed4944b2d18ac5fc00c2e2
Autor:
Emily Corse, Abhishek Kashyap, Brianna Flynn, Jeanine Pignatelli, Kang Liu, Nikita Sharma, Priya Govindaraju, Shermineh Bradford, Yarong Wang, Candace Wai Sze Lei, Varenka Rodriguez Di Blasi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/38d3c451398843059d25f08e46f47178
Autor:
José Baselga, Claudia Aura, José Jimenez, Ludmila Prudkin, Varenka Rodriguez, Kip A. West, Kelly L. Slocum, Alice R. Lim, Olga Rodriguez, Marta Guzman, Emmanuel Normant, Violeta Serra, Maurizio Scaltriti
Supplementary Figure 3 from Antitumor Activity of the Hsp90 Inhibitor IPI-504 in HER2-Positive Trastuzumab-Resistant Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86f6adafe9a431b9bcbd2909aa5581fe
https://doi.org/10.1158/1535-7163.22497190
https://doi.org/10.1158/1535-7163.22497190
Autor:
José Baselga, Claudia Aura, José Jimenez, Ludmila Prudkin, Varenka Rodriguez, Kip A. West, Kelly L. Slocum, Alice R. Lim, Olga Rodriguez, Marta Guzman, Emmanuel Normant, Violeta Serra, Maurizio Scaltriti
Supplementary Figure 1 from Antitumor Activity of the Hsp90 Inhibitor IPI-504 in HER2-Positive Trastuzumab-Resistant Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bad67847ef5041dbe893b8aa7bc98cb
https://doi.org/10.1158/1535-7163.22497196
https://doi.org/10.1158/1535-7163.22497196
Autor:
José Baselga, Claudia Aura, José Jimenez, Ludmila Prudkin, Varenka Rodriguez, Kip A. West, Kelly L. Slocum, Alice R. Lim, Olga Rodriguez, Marta Guzman, Emmanuel Normant, Violeta Serra, Maurizio Scaltriti
Supplementary Figure 2 from Antitumor Activity of the Hsp90 Inhibitor IPI-504 in HER2-Positive Trastuzumab-Resistant Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57460a9bcd3d82a689dda3fd312a969e
https://doi.org/10.1158/1535-7163.22497193
https://doi.org/10.1158/1535-7163.22497193
Autor:
José Baselga, Claudia Aura, José Jimenez, Ludmila Prudkin, Varenka Rodriguez, Kip A. West, Kelly L. Slocum, Alice R. Lim, Olga Rodriguez, Marta Guzman, Emmanuel Normant, Violeta Serra, Maurizio Scaltriti
Supplementary Figure Legends 1-3 from Antitumor Activity of the Hsp90 Inhibitor IPI-504 in HER2-Positive Trastuzumab-Resistant Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e8af4d7bd1c867b5a33e4eca1792778
https://doi.org/10.1158/1535-7163.22497187.v1
https://doi.org/10.1158/1535-7163.22497187.v1
Autor:
Pratha Budhani, Brianna Flynn, Robert Norgard, Joshua Tagore, Lucinda Thiede, John Holt, Shengyang Wu, Chris Kang, Xiaobin Wang, Jessica Potts, Charlie Cote, Greg Peet, Ruby Wasti, Mohanapriya Kamalakannan, Varenka Rodriguez DiBlasi, Sarah O’Brien, Abhishek Kashyap, Kang Liu
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Robert J Norgard, Pratha Budhani, Sarah O'Brian, Jessica Potts, Brianna Flynn, Xavier Salce, Joshua Tagore, Lucinda Thiede, Joseph Seco, Suzanne Segal, Mark Love, Ania Mikucka, Charlie Cote, Ruby Wasti, Mohanapriya Kamalakannan, Astrid Jeschko, Gabriela Melo-Zainzinger, Angela Mcnabola, Varenka Rodriguez Rodriguez DiBlasi, Joseph Tumang, Ulrike Tontsch-Grunt, Melanie Hinkel, Jeanine Pignatelli, Francesca Trapani, Sandra Martinez-Morilla, Kaja Kostyrko, Marco H Hofmann, Abhishek Kashyap, Emilio Flano, Kang Liu
Publikováno v:
Cancer Immunology Research. 10:B23-B23
KRAS is most frequently mutated in pancreatic adenocarcinomas (PDAC) with more than 90% of cases having a KRAS mutation. This leads to constitutive activation of the downstream signaling pathways, driving tumor cell proliferation whilst co-opting the
Autor:
Pratha Budhani, Xiaoyun Liao, Lucinda Thiede, Varenka Rodriguez DiBlasi, Marie Marcher, Candace Wai Sze Lei, Jeanine Pignatelli, Ben Z. Stanger, Kang Liu, Joseph Tumang, Jacqueline Larouche, Abhishek S. Kashyap, John Holt, Jessica Potts, Ellen Puré, Ruby Wasti, Mohanapriya Kamalakannan, Richard Barrett, Emily Corse, Brianna Flynn, Joshua Tagore, Sarah O’Brien
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundPancreatic ductal adenocarcinoma (PDAC) is resistant to many available therapies including immunotherapy because of its highly complex tumor microenvironment (TME). PDAC TME consists of a significant proportion of stromal cells, such as end
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.